Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols

ChemMedChem. 2007 Dec;2(12):1750-62. doi: 10.1002/cmdc.200700149.

Abstract

Aromatase, an enzyme of the cytochrome P450 family, is a very important pharmacological target, particularly for the treatment of breast cancer. The anti-aromatase activity of a set of natural polyphenolic compounds was evaluated in vitro. Strong aromatase inhibitors including flavones, flavanones, resveratrol, and oleuropein, with activities comparable to that of the reference anti-aromatase drug aminoglutethimide, were identified. Through the application of molecular modeling techniques based on grid-independent descriptors and molecular interaction fields, the major physicochemical features associated with inhibitory activity were disclosed, and a putative virtual active site of aromatase was proposed. Docking of the inhibitors into a 3D homology model structure of the enzyme defined a common binding mode for the small molecules under investigation. The good correlation between computational and biological results provides the first rationalization of the anti-aromatase activity of polyphenolic compounds. Moreover, the information generated in this approach should be further exploited for the design of new aromatase inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aromatase Inhibitors / chemistry*
  • Aromatase Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Female
  • Flavonoids / chemistry*
  • Flavonoids / pharmacology*
  • Humans
  • Microsomes / drug effects
  • Models, Molecular
  • Molecular Conformation
  • Phenols / chemistry*
  • Phenols / pharmacology*
  • Placenta / drug effects
  • Polyphenols
  • Structure-Activity Relationship

Substances

  • Aromatase Inhibitors
  • Flavonoids
  • Phenols
  • Polyphenols